Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy UBS Group AG

Crinetics Pharmaceuticals Inc
Start price
€36.65
02.07.26 / 50%
Target price
€48.33
02.07.27
Performance (%)
99.73%
Price
€73.20
17.08.26
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Crinetics Pharmaceuticals Inc has seen massive gains of 99.73%. This prediction currently runs until 02.07.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Crinetics Pharmaceuticals Inc 0.384% 0.384%
iShares Core DAX® -0.046% 5.960%
iShares Nasdaq 100 0.922% 3.693%
iShares Nikkei 225® 3.014% 6.638%
iShares S&P 500 -0.359% 2.747%

Comments by UBS_Group_AG for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 99.73%
Target price 48.329
Change
Ends at 02.07.27

Crinetics Pharmaceuticals (CRNX) is now covered by UBS Group AG. They set a "buy" rating and a $55.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat

UBS Group AG 
0
Report Share
02.07.26